
{"id":248454,"date":"2021-02-04T11:51:27","date_gmt":"2021-02-04T10:51:27","guid":{"rendered":"https:\/\/www.fqeuskadi.org\/?p=248454"},"modified":"2022-10-03T11:47:42","modified_gmt":"2022-10-03T09:47:42","slug":"boletin-asociacion-europea-de-fq","status":"publish","type":"post","link":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/","title":{"rendered":"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; custom_margin=&#8221;15px||||false|false&#8221; sticky_enabled=&#8221;0&#8243;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Bolet\u00edn sobre el proyecto de investigaci\u00f3n HIT-CF Europe<\/h3>\n<p>La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica ha publicado su bolet\u00edn informativo de enero 2021 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.<\/p>\n<p>Este proyecto tiene como objetivo <strong>evaluar la eficacia y seguridad de diferentes f\u00e1rmacos<\/strong> moduladores CFTR en pacientes con FQ y mutaciones raras basadas en la respuesta de organoides intestinales.<\/p>\n<p><span style=\"font-size: 14px;\">Fuente: <\/span><a href=\"https:\/\/fibrosisquistica.org\/\" target=\"_blank\" rel=\"noopener noreferrer\" style=\"font-size: 14px;\">https:\/\/fibrosisquistica.org\/<\/a><\/p>\n<p>A continuaci\u00f3n, os dejamos el bolet\u00edn informativo del proyecto HIT-CF Europe traducido al espa\u00f1ol.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>HIT-CF ikerketaren-proiectuari buruzko buletina<\/h3>\n<p>Fibrosi Kistikoaren Europako Elkarteak 2021eko urtarrileko informazio-buletina argitaratu du, HIT-CF Europe ikerketa-proiektuaren bilakaerari buruzkoa.<\/p>\n<p>Proiektu honen helburua da CFTR <strong>farmako modulatzaileen eraginkortasuna eta segurtasuna ebaluatzea <\/strong>FK duten pazienteetan eta hesteetako organoideen erantzunean oinarritutako mutazio arraroetan.<\/p>\n<p>Iturria: <a href=\"https:\/\/fibrosisquistica.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/fibrosisquistica.org\/<\/a><\/p>\n<p>Hona hemen HIT-CF Europe proiektuaren informazio-buletina, gaztelaniara itzulia.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica ha publicado su bolet\u00edn informativo de enero 2021 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.<\/p>\n","protected":false},"author":1,"featured_media":252765,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[47],"tags":[],"class_list":["post-248454","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fq-berriak"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bolet\u00edn de La Asociaci\u00f3n Europea de FQ - FQ EUSKADI<\/title>\n<meta name=\"description\" content=\"La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica ha publicado su bolet\u00edn informativo de enero 2021 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ - FQ EUSKADI\" \/>\n<meta property=\"og:description\" content=\"La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica ha publicado su bolet\u00edn informativo de enero 2021 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/\" \/>\n<meta property=\"og:site_name\" content=\"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fqeuskadi\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-04T10:51:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-03T09:47:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"631\" \/>\n\t<meta property=\"og:image:height\" content=\"913\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"fqeuskadi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@fqeuskadi\" \/>\n<meta name=\"twitter:site\" content=\"@fqeuskadi\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fqeuskadi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minutua\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/\"},\"author\":{\"name\":\"fqeuskadi\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/78417e37f3c9ac22ed797acb51941f81\"},\"headline\":\"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ\",\"datePublished\":\"2021-02-04T10:51:27+00:00\",\"dateModified\":\"2022-10-03T09:47:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/\"},\"wordCount\":247,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg\",\"articleSection\":[\"FQ BERRIAK\"],\"inLanguage\":\"eu\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/\",\"url\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/\",\"name\":\"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ - FQ EUSKADI\",\"isPartOf\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg\",\"datePublished\":\"2021-02-04T10:51:27+00:00\",\"dateModified\":\"2022-10-03T09:47:42+00:00\",\"description\":\"La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica ha publicado su bolet\u00edn informativo de enero 2021 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#breadcrumb\"},\"inLanguage\":\"eu\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"eu\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#primaryimage\",\"url\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg\",\"contentUrl\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg\",\"width\":631,\"height\":913,\"caption\":\"Boletin asociacion europea\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.fqeuskadi.org\/eu\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#website\",\"url\":\"https:\/\/www.fqeuskadi.org\/\",\"name\":\"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI\",\"description\":\"FQ Euskadi trabaja por las personas con Fibrosis qu\u00edstica. Desde Fq Euskadi ayudamos con nuestra labor y servicios a unas 90 familias con FQ.\",\"publisher\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fqeuskadi.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"eu\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#organization\",\"name\":\"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI\",\"url\":\"https:\/\/www.fqeuskadi.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg\",\"contentUrl\":\"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg\",\"width\":1950,\"height\":532,\"caption\":\"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI\"},\"image\":{\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/fqeuskadi\/\",\"https:\/\/x.com\/fqeuskadi\",\"https:\/\/www.instagram.com\/fqeuskadi\/\",\"https:\/\/www.youtube.com\/channel\/UCyqLMZSfydAklJH1x-Js97w\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/78417e37f3c9ac22ed797acb51941f81\",\"name\":\"fqeuskadi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu\",\"@id\":\"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4d4b968324a61b6ab351d54d36bc5898?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4d4b968324a61b6ab351d54d36bc5898?s=96&d=mm&r=g\",\"caption\":\"fqeuskadi\"},\"description\":\"Asociaci\u00f3n dedicada a la mejora de la calidad de vida de las personas con fibrosis quistica fqeuskadi\",\"sameAs\":[\"https:\/\/www.fqeuskadi.org\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ - FQ EUSKADI","description":"La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica ha publicado su bolet\u00edn informativo de enero 2021 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/","og_locale":"en_US","og_type":"article","og_title":"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ - FQ EUSKADI","og_description":"La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica ha publicado su bolet\u00edn informativo de enero 2021 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.","og_url":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/","og_site_name":"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI","article_publisher":"https:\/\/www.facebook.com\/fqeuskadi\/","article_published_time":"2021-02-04T10:51:27+00:00","article_modified_time":"2022-10-03T09:47:42+00:00","og_image":[{"width":631,"height":913,"url":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg","type":"image\/jpeg"}],"author":"fqeuskadi","twitter_card":"summary_large_image","twitter_creator":"@fqeuskadi","twitter_site":"@fqeuskadi","twitter_misc":{"Written by":"fqeuskadi","Est. reading time":"1 minutua"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#article","isPartOf":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/"},"author":{"name":"fqeuskadi","@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/78417e37f3c9ac22ed797acb51941f81"},"headline":"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ","datePublished":"2021-02-04T10:51:27+00:00","dateModified":"2022-10-03T09:47:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/"},"wordCount":247,"commentCount":0,"publisher":{"@id":"https:\/\/www.fqeuskadi.org\/#organization"},"image":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg","articleSection":["FQ BERRIAK"],"inLanguage":"eu","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/","url":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/","name":"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ - FQ EUSKADI","isPartOf":{"@id":"https:\/\/www.fqeuskadi.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#primaryimage"},"image":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg","datePublished":"2021-02-04T10:51:27+00:00","dateModified":"2022-10-03T09:47:42+00:00","description":"La Asociaci\u00f3n Europea de Fibrosis Qu\u00edstica ha publicado su bolet\u00edn informativo de enero 2021 sobre la evoluci\u00f3n del proyecto de investigaci\u00f3n HIT-CF Europe.","breadcrumb":{"@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#breadcrumb"},"inLanguage":"eu","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/"]}]},{"@type":"ImageObject","inLanguage":"eu","@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#primaryimage","url":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg","contentUrl":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/02\/Boletin-asociacion-europea-1.jpg","width":631,"height":913,"caption":"Boletin asociacion europea"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fqeuskadi.org\/eu\/boletin-asociacion-europea-de-fq\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.fqeuskadi.org\/eu\/home\/"},{"@type":"ListItem","position":2,"name":"Bolet\u00edn de La Asociaci\u00f3n Europea de FQ"}]},{"@type":"WebSite","@id":"https:\/\/www.fqeuskadi.org\/#website","url":"https:\/\/www.fqeuskadi.org\/","name":"FQ EUSKADI - ASOCIACI\u00d3N FIBROSIS QU\u00cdSTICA EUSKADI","description":"FQ Euskadi trabaja por las personas con Fibrosis qu\u00edstica. Desde Fq Euskadi ayudamos con nuestra labor y servicios a unas 90 familias con FQ.","publisher":{"@id":"https:\/\/www.fqeuskadi.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fqeuskadi.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"eu"},{"@type":"Organization","@id":"https:\/\/www.fqeuskadi.org\/#organization","name":"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI","url":"https:\/\/www.fqeuskadi.org\/","logo":{"@type":"ImageObject","inLanguage":"eu","@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg","contentUrl":"https:\/\/www.fqeuskadi.org\/wp-content\/uploads\/2021\/11\/2021_ARNASA_EUSKADI-1-e1637833605457.jpg","width":1950,"height":532,"caption":"ASOCIACI\u00d3N DE FIBROSIS QU\u00cdSTICA DE EUSKADI"},"image":{"@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/fqeuskadi\/","https:\/\/x.com\/fqeuskadi","https:\/\/www.instagram.com\/fqeuskadi\/","https:\/\/www.youtube.com\/channel\/UCyqLMZSfydAklJH1x-Js97w"]},{"@type":"Person","@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/78417e37f3c9ac22ed797acb51941f81","name":"fqeuskadi","image":{"@type":"ImageObject","inLanguage":"eu","@id":"https:\/\/www.fqeuskadi.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4d4b968324a61b6ab351d54d36bc5898?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4d4b968324a61b6ab351d54d36bc5898?s=96&d=mm&r=g","caption":"fqeuskadi"},"description":"Asociaci\u00f3n dedicada a la mejora de la calidad de vida de las personas con fibrosis quistica fqeuskadi","sameAs":["https:\/\/www.fqeuskadi.org"]}]}},"_links":{"self":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/posts\/248454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/comments?post=248454"}],"version-history":[{"count":0,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/posts\/248454\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/media\/252765"}],"wp:attachment":[{"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/media?parent=248454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/categories?post=248454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fqeuskadi.org\/eu\/wp-json\/wp\/v2\/tags?post=248454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}